Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The GLP-1 Bridge Program is a time-limited program that will provide eligible Medicare beneficiaries with access to certain GLP-1 drugs outside of the Part D benefit
Ro said it hopes its new tool will be able to help patients understand their coverage options so they can decide how to pursue weight loss, and it could also drive some patients to join the company's GLP-1 program
Side effects, safety, and tolerability Both medications (tirzepatide and orforglipron) are GLP-1-based and share the same side effects profile as other GLP-1 receptor agonists used for diabetes and weight management
PMID: 41754849
US$ 20.09
US$ 23.84
